Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$4.39 - $7.23 $758,592 - $1.25 Million
-172,800 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$3.86 - $5.07 $13,896 - $18,252
-3,600 Reduced 2.04%
172,800 $746,000
Q3 2020

Nov 05, 2020

BUY
$4.11 - $6.45 $18,495 - $29,025
4,500 Added 2.62%
176,400 $725,000
Q2 2020

Aug 12, 2020

BUY
$5.75 - $11.99 $924,600 - $1.93 Million
160,800 Added 1448.65%
171,900 $1.03 Million
Q4 2019

Jan 27, 2020

BUY
$10.15 - $15.58 $112,665 - $172,938
11,100 New
11,100 $153,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.